Literature DB >> 10336115

Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.

M Lindskog1, P Svenningsson, B B Fredholm, P Greengard, G Fisone.   

Abstract

The vast majority of striatal neurons are GABAergic medium-sized spiny neurons. These cells receive glutamatergic input from the cortex, thalamus and limbic areas and dopaminergic input from the mesencephalon. Most relevant evidence indicates that dopamine D1 receptors are located on striatonigral projection neurons, and that adenosine A2A receptors and most dopamine D2 receptors are located on striatopallidal projection neurons (see, however, Refs I and 13). Here we have utilized regulation of the phosphorylation of dopamine- and cyclic AMP-regulated phosphoprotein of mol. wt 32,000 (DARPP-32) to study the possible interactions among nigrostriatal dopaminergic neurons and the two classes of dopaminoceptive target neurons. We show that, in striatal slices, the D2 receptor agonist, quinpirole, strongly inhibits the phosphorylation of DARPP-32 induced by either the D1 receptor agonist, SKF 81297, or the A2A receptor agonist, CGS 21680. Tetrodotoxin abolished the effect of quinpirole on the D1 agonist-induced but not the A2A agonist-induced phosphorylation of DARPP-32. These data indicate that: (i) adenosine A2A and dopamine D2 receptors interact within the same striatopallidal neurons, and (ii) D2 receptors present on the striatopallidal neurons modulate the effects of D1 receptors on the striatonigral neurons. Thus, a single neurotransmitter is capable of activating distinct classes of receptors on distinct populations of target neurons, which, in turn, interact with each other through intercellular communication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336115     DOI: 10.1016/s0306-4522(98)00411-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 2.  Adenosine A2A receptors and basal ganglia physiology.

Authors:  S N Schiffmann; G Fisone; R Moresco; R A Cunha; S Ferré
Journal:  Prog Neurobiol       Date:  2007-06-26       Impact factor: 11.685

3.  Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.

Authors:  Silva Fredduzzi; Rosario Moratalla; Angela Monopoli; Beatriz Cuellar; Kui Xu; Ennio Ongini; Francesco Impagnatiello; Michael A Schwarzschild; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates.

Authors:  S A Treseder; M Jackson; P Jenner
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  DARPP-32 mediates serotonergic neurotransmission in the forebrain.

Authors:  Per Svenningsson; Eleni T Tzavara; Feng Liu; Allen A Fienberg; George G Nomikos; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  Downregulation of the cAMP/PKA pathway in PC12 cells overexpressing NCS-1.

Authors:  Bruno R Souza; Karen C L Torres; Débora M Miranda; Bernardo S Motta; Fernando S Caetano; Daniela V F Rosa; Renan P Souza; Antônio Giovani; Daniel S Carneiro; Melissa M Guimarães; Cristina Martins-Silva; Helton J Reis; Marcus V Gomez; Andreas Jeromin; Marco A Romano-Silva
Journal:  Cell Mol Neurobiol       Date:  2010-09-14       Impact factor: 5.046

7.  DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics.

Authors:  Bruno R Souza; Bernardo S Motta; Daniela V F Rosa; Karen C L Torres; Adalberto A Castro; Clarissa M Comim; André M Sampaio; Fabrício F Lima; Andreas Jeromin; João Quevedo; Marco A Romano-Silva
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

8.  Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha.

Authors:  Tie-Shan Tang; Huiping Tu; Zhengnan Wang; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Dopamine and cyclic-AMP regulated phosphoprotein-32-dependent modulation of prefrontal cortical input and intercellular coupling in mouse accumbens spiny and aspiny neurons.

Authors:  S-P Onn; M Lin; J-J Liu; A A Grace
Journal:  Neuroscience       Date:  2007-11-28       Impact factor: 3.590

10.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.